These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8539363)

  • 1. Nova Scotia Breast Screening Program experience: use of needle core biopsy in the diagnosis of screening-detected abnormalities.
    Caines JS; Chantziantoniou K; Wright BA; Konok GP; Iles SE; Bodurtha A; Zayid I; Daniels C
    Radiology; 1996 Jan; 198(1):125-30. PubMed ID: 8539363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten years of breast screening in the Nova Scotia Breast Screening Program, 1991-2001. experience: use of an adaptable stereotactic device in the diagnosis of screening-detected abnormalities.
    Caines JS; Schaller GH; Iles SE; Woods ER; Barnes PJ; Johnson AJ; Jones GR; Borgaonkar JN; Rowe JA; Topp TJ; Porter GA
    Can Assoc Radiol J; 2005 Apr; 56(2):82-93. PubMed ID: 15957275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening mammography: value in women 35-39 years old.
    Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
    AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpalpable breast lesions: findings of stereotaxic needle-core biopsy and fine-needle aspiration cytology.
    Dowlatshahi K; Yaremko ML; Kluskens LF; Jokich PM
    Radiology; 1991 Dec; 181(3):745-50. PubMed ID: 1947091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of interval breast cancers diagnosed among participants of the Nova Scotia Breast Screening Program.
    Payne JI; Caines JS; Gallant J; Foley TJ
    Radiology; 2013 Jan; 266(1):96-103. PubMed ID: 23169791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations.
    Kolb TM; Lichy J; Newhouse JH
    Radiology; 2002 Oct; 225(1):165-75. PubMed ID: 12355001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Needle core biopsy guided with mammography: a study of cost-effectiveness.
    Lindfors KK; Rosenquist CJ
    Radiology; 1994 Jan; 190(1):217-22. PubMed ID: 8259408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
    Hofvind S; Thoresen S; Tretli S
    Cancer; 2004 Oct; 101(7):1501-7. PubMed ID: 15378474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
    Duijm LE; Groenewoud JH; Roumen RM; de Koning HJ; Plaisier ML; Fracheboud J
    Breast Cancer Res Treat; 2007 Nov; 106(1):113-9. PubMed ID: 17219049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of false-positive results in analog and digital screening mammography: experience of the Nova Scotia Breast Screening Program.
    Payne JI; Martin T; Caines JS; Duggan R
    Can Assoc Radiol J; 2014 Nov; 65(4):315-20. PubMed ID: 25134453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic core needle biopsy of nonpalpable breast lesions using a conventional mammography unit with an add-on device.
    Kirshenbaum KJ; Voruganti T; Overbeeke C; Kirshenbaum MD; Patel P; Kaplan G; Maker V; August C; Cavallino RP
    AJR Am J Roentgenol; 2003 Aug; 181(2):527-31. PubMed ID: 12876040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic breast cancer screening in Hong Kong; a revisit of the Kwong Wah Hospital experience.
    Lui CY; Lam HS; Chan LK; Tam KF; Chan CM; Leung TY; Mak KL
    Hong Kong Med J; 2007 Apr; 13(2):106-13. PubMed ID: 17406037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunistic breast cancer early detection in Tyrol, Austria 1996-2004. Is a mammography-screening program necessary?
    Frede TE
    Eur J Radiol; 2005 Jul; 55(1):130-8. PubMed ID: 15925467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy.
    Sydnor MK; Wilson JD; Hijaz TA; Massey HD; Shaw de Paredes ES
    Radiology; 2007 Jan; 242(1):58-62. PubMed ID: 17090707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core needle biopsy of synchronous ipsilateral breast lesions: impact on treatment.
    Liberman L; Dershaw DD; Rosen PP; Morris EA; Cohen MA; Abramson AF
    AJR Am J Roentgenol; 1996 Jun; 166(6):1429-32. PubMed ID: 8633457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast MR imaging screening in women with a history of breast conservation therapy.
    Gweon HM; Cho N; Han W; Yi A; Moon HG; Noh DY; Moon WK
    Radiology; 2014 Aug; 272(2):366-73. PubMed ID: 24635678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective use of image-guided large-core needle biopsy of the breast: accuracy and cost-effectiveness.
    Doyle AJ; Murray KA; Nelson EW; Bragg DG
    AJR Am J Roentgenol; 1995 Aug; 165(2):281-4. PubMed ID: 7618540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic core-needle biopsy of non-mass calcifications: outcome and accuracy at long-term follow-up.
    Han BK; Choe YH; Ko YH; Nam SJ; Kim JH; Yang JH
    Korean J Radiol; 2003; 4(4):217-23. PubMed ID: 14726638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.